Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function ...

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

Background: People with profound intellectual and multiple disabilities (PIMD) living in residential care facilities receive continence care at scheduled times. This can result in leakage or ...

(NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased ...

Profound Medical ( ($TSE:PRN) ) has shared an announcement. Profound Medical announced that The Johns Hopkins Hospital has performed its first ...

Profound Medical (PROF) announced that The Johns Hopkins Hospital has treated its first non-clinical-trial prostate cancer patient using the ...

The Pitt Season 2 continues to examine the hospital system through a clear-eyed and humanist lens, an enthralling mix of grit ...

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private ...

Shares of Profound Medical declined after the medical-device company said it planned to increase the size of its private placement. The stock fell 2.5%, to $7.32, late Friday morning, and shares are ...